chr3-15458206-T-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_005677.4(COLQ):​c.934A>G​(p.Ser312Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0191 in 1,613,888 control chromosomes in the GnomAD database, including 1,008 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.049 ( 455 hom., cov: 32)
Exomes 𝑓: 0.016 ( 553 hom. )

Consequence

COLQ
NM_005677.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.951

Publications

7 publications found
Variant links:
Genes affected
COLQ (HGNC:2226): (collagen like tail subunit of asymmetric acetylcholinesterase) This gene encodes the subunit of a collagen-like molecule associated with acetylcholinesterase in skeletal muscle. Each molecule is composed of three identical subunits. Each subunit contains a proline-rich attachment domain (PRAD) that binds an acetylcholinesterase tetramer to anchor the catalytic subunit of the enzyme to the basal lamina. Mutations in this gene are associated with endplate acetylcholinesterase deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
COLQ Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 16 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Gene score misZ: -0.21928 (below the threshold of 3.09). Trascript score misZ: -0.17745 (below the threshold of 3.09). GenCC associations: The gene is linked to congenital myasthenic syndrome 5.
BP4
Computational evidence support a benign effect (MetaRNN=0.0016097426).
BP6
Variant 3-15458206-T-C is Benign according to our data. Variant chr3-15458206-T-C is described in ClinVar as Benign. ClinVar VariationId is 128827.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COLQNM_005677.4 linkc.934A>G p.Ser312Gly missense_variant Exon 13 of 17 ENST00000383788.10 NP_005668.2
COLQNM_080538.2 linkc.904A>G p.Ser302Gly missense_variant Exon 13 of 17 NP_536799.1
COLQNM_080539.4 linkc.832A>G p.Ser278Gly missense_variant Exon 12 of 16 NP_536800.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COLQENST00000383788.10 linkc.934A>G p.Ser312Gly missense_variant Exon 13 of 17 1 NM_005677.4 ENSP00000373298.3
COLQENST00000603808.5 linkc.934A>G p.Ser312Gly missense_variant Exon 13 of 17 1 ENSP00000474271.1

Frequencies

GnomAD3 genomes
AF:
0.0494
AC:
7523
AN:
152142
Hom.:
454
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0234
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0216
Gnomad FIN
AF:
0.00989
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0132
Gnomad OTH
AF:
0.0454
GnomAD2 exomes
AF:
0.0216
AC:
5425
AN:
251474
AF XY:
0.0202
show subpopulations
Gnomad AFR exome
AF:
0.147
Gnomad AMR exome
AF:
0.0118
Gnomad ASJ exome
AF:
0.00883
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0109
Gnomad NFE exome
AF:
0.0122
Gnomad OTH exome
AF:
0.0192
GnomAD4 exome
AF:
0.0160
AC:
23364
AN:
1461628
Hom.:
553
Cov.:
32
AF XY:
0.0163
AC XY:
11864
AN XY:
727122
show subpopulations
African (AFR)
AF:
0.149
AC:
4977
AN:
33474
American (AMR)
AF:
0.0132
AC:
589
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0113
AC:
295
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0267
AC:
2305
AN:
86240
European-Finnish (FIN)
AF:
0.0131
AC:
699
AN:
53418
Middle Eastern (MID)
AF:
0.0412
AC:
230
AN:
5586
European-Non Finnish (NFE)
AF:
0.0116
AC:
12901
AN:
1111992
Other (OTH)
AF:
0.0226
AC:
1367
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1297
2594
3892
5189
6486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0495
AC:
7535
AN:
152260
Hom.:
455
Cov.:
32
AF XY:
0.0474
AC XY:
3527
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.143
AC:
5919
AN:
41530
American (AMR)
AF:
0.0233
AC:
357
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.0218
AC:
105
AN:
4820
European-Finnish (FIN)
AF:
0.00989
AC:
105
AN:
10612
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0132
AC:
901
AN:
68034
Other (OTH)
AF:
0.0449
AC:
95
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
342
683
1025
1366
1708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0266
Hom.:
506
Bravo
AF:
0.0549
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00908
AC:
35
ESP6500AA
AF:
0.141
AC:
623
ESP6500EA
AF:
0.0138
AC:
119
ExAC
AF:
0.0244
AC:
2960
Asia WGS
AF:
0.0140
AC:
51
AN:
3478
EpiCase
AF:
0.0150
EpiControl
AF:
0.0147

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 04, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Congenital myasthenic syndrome 5 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
15
DANN
Benign
0.92
DEOGEN2
Benign
0.20
T;.;.;.
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.65
T;T;T;T
MetaRNN
Benign
0.0016
T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.20
N;.;.;.
PhyloP100
0.95
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.14
N;N;.;N
REVEL
Benign
0.17
Sift
Benign
0.32
T;T;.;.
Sift4G
Benign
0.60
T;T;T;T
Polyphen
0.0040
B;B;.;B
Vest4
0.081
MPC
0.089
ClinPred
0.0065
T
GERP RS
2.3
Varity_R
0.031
gMVP
0.25
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6782980; hg19: chr3-15499713; API